---
title: "Alphatec Holdings plunges 40% as it cuts full-year revenue guidance"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/303757427.md"
description: "Alphatec Holdings fell 39.75% to $6.85 after cutting FY2026 revenue guidance to $862 million on biologics attrition and weak demand."
datetime: "2026-10-30T13:31:12.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/303757427.md)
  - [en](https://longbridge.com/en/news/303757427.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/303757427.md)
generator: "portal-rs"
---

# Alphatec Holdings plunges 40% as it cuts full-year revenue guidance

Alphatec Holdings (ATEC.US) plunged nearly **40%** during regular trading to **$6.85**.

The company cut its fiscal 2026 revenue guidance to **$862 million** and projected adjusted EBITDA of **$137 million** following third-quarter results released on Oct. 29. Although total third-quarter revenue rose about 12.6% year-over-year to **$221 million** with surgical volumes up 20%, biologics attrition and weak thoracolumbar demand constrained growth, prompting the lowered full-year outlook.

Separately, Alphatec reported a third-quarter net loss attributable to shareholders of **$5.47 million**, narrowing about 80.9% from a year earlier. The company achieved its first GAAP operating profit of **$3.2 million**, driven by improved margins and lower litigation costs.

Based on public media reports. AI-generated; not investment advice.

### Related Stocks

- [ATEC.US](https://longbridge.com/en/quote/ATEC.US.md)

## Related News & Research

- [Did Alphatec's Fall Catch You Out? What Investors Missed](https://longbridge.com/en/news/303089224.md)
- [ATEC: Surgical demand strengthened, but biologics attachment constrained Q3 revenue](https://longbridge.com/en/news/303621217.md)
- [ATEC Q3 2026 Earnings: Biologics Weakness Limits Revenue Growth](https://longbridge.com/en/news/303624186.md)
- [JP Morgan maintains Alphatec Holdings at Overweight, lowers price target to $15 from $16](https://longbridge.com/en/news/303811177.md)
- [Tempus AI Earnings Ahead: Is TEM Set Up To Pop or Drop?](https://longbridge.com/en/news/303867113.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**